Intervention
Bone Marrow Aspiration
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownQ702 for the Treatment of Patients With Hematologic MalignanciesNCT06712810 · 2025-08-27
RECRUITINGTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialNCT05564377 · 2023-04-07
RECRUITINGAMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")NCT07649304 · 2026-10-09
NOT_YET_RECRUITINGTesting Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast CancerNCT02849496 · 2017-03-30
ACTIVE_NOT_RECRUITINGKinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild AsthmaticsNCT01420003 · 2011-11-01
COMPLETEDDiagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast CancerNCT00089323 · 2007-01-01
COMPLETEDCommon conditions
Anatomic Stage III Breast Cancer AJCC v82Anatomic Stage IV Breast Cancer AJCC v82Advanced Malignant Solid Neoplasm1AIDS-Related Diffuse Large B-cell Lymphoma1Atopic Asthma1Breast Cancer1Diffuse Large B-Cell Lymphoma, Not Otherwise Specified1Hematopoietic and Lymphatic System Neoplasm1High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements1High Grade B-Cell Lymphoma, Not Otherwise Specified1Histiocytic Sarcoma1Locally Advanced Malignant Solid Neoplasm1Locally Advanced Unresectable Breast Carcinoma1Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v81Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v81Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v81Malignant Female Reproductive System Neoplasm1Malignant Histiocytosis1Metastatic Breast Carcinoma1Metastatic HER2-Negative Breast Carcinoma1Metastatic Malignant Solid Neoplasm1Peripheral T-Cell Lymphoma, Not Otherwise Specified1Plasmablastic Lymphoma1Primary Central Nervous System Lymphoma1Primary Cutaneous T-Cell Non-Hodgkin Lymphoma1
Leading sponsors
Trial status mix
COMPLETED2
RECRUITING2
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
Phase mix
NA2
PHASE12
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.